Related Experiment Video
Updated: Mar 7, 2026

05:09
Author Spotlight: Quantifying Siderophores and Pyochelin for Infection Control
Published on: March 15, 2024
6.3K
Substrate Trapping in the Siderophore Tailoring Enzyme PvdQ
Kenneth D Clevenger1, Romila Mascarenhas2, Daniel Catlin2
1Department of Chemistry, Northwestern University , Evanston, Illinois 60208, United States.
ACS Chemical Biology
|February 11, 2017
Summary
Pseudomonas aeruginosa pyoverdine biosynthesis is key to its virulence. Researchers studied the PvdQ enzyme, finding its structure and interactions with a pyoverdine precursor, which could aid drug design.
Area of Science:
- Microbiology
- Structural Biology
- Biochemistry
Background:
- Pseudomonas aeruginosa utilizes siderophore biosynthesis, particularly pyoverdine, to enhance virulence.
- The enzyme PvdQ is crucial in the pyoverdine pathway, cleaving a myristoyl anchor from a precursor.
- Targeting siderophore biosynthesis presents a promising strategy for developing new antimicrobial therapies.
Purpose of the Study:
- To characterize the structure and function of PvdQ, an enzyme involved in pyoverdine biosynthesis.
- To investigate a circularly permuted variant of PvdQ (cpPvdQ) for potential therapeutic applications.
- To elucidate the binding interactions between PvdQ and its pyoverdine precursor.
Main Methods:
- X-ray crystallography was used to determine the high-resolution structures of wild-type PvdQ and a mutant form.
- Biochemical assays were employed to assess the activity and selectivity of PvdQ and its variants.
- Structural analysis of the PvdQ-precursor complex provided insights into substrate binding.
Main Results:
- A circularly permuted PvdQ (cpPvdQ) retained wild-type activity, selectivity, and structure, bypassing self-processing.
- The X-ray crystal structure of an inactive mutant complexed with the pyoverdine precursor PVDIq revealed a specific binding pocket.
- This is the first reported structure of a pyoverdine precursor bound to its biosynthetic enzyme.
Conclusions:
- The structural and functional characterization of PvdQ and its cpPvdQ variant offers insights into pyoverdine biosynthesis.
- Understanding the specific binding interactions can inform the design of novel inhibitors targeting PvdQ.
- These findings have significant implications for developing new drugs against Pseudomonas aeruginosa infections.

